Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | lamin dm0 | 0.0026 | 1 | 0.5 |
Onchocerca volvulus | 0.0026 | 1 | 0.5 | |
Brugia malayi | hypothetical protein | 0.0016 | 0.1458 | 0.1458 |
Echinococcus multilocularis | lamin | 0.0026 | 1 | 0.5 |
Schistosoma mansoni | intermediate filament proteins | 0.0026 | 1 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.8593 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0025 | 0.8593 | 0.8593 |
Echinococcus multilocularis | musashi | 0.0026 | 1 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.8593 | 0.5 |
Schistosoma mansoni | lamin | 0.0026 | 1 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.8593 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.8593 | 0.5 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.8593 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.9606 | 0.9606 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.8593 | 0.5 |
Onchocerca volvulus | 0.0026 | 1 | 0.5 | |
Echinococcus multilocularis | lamin dm0 | 0.0026 | 1 | 0.5 |
Schistosoma mansoni | lamin | 0.0026 | 1 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.8593 | 0.5 |
Echinococcus granulosus | lamin | 0.0026 | 1 | 0.5 |
Echinococcus granulosus | intermediate filament protein | 0.0026 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.8593 | 0.8593 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.8593 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0026 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.